ROB’S CHOICE / INFLAMMATION & HEALTH
Understand the health concern.
Look into the ingredient evidence.
Inflammation helps fight infection and repair injury. In chronic inflammatory conditions, it drives tissue damage. Its role differs across diseases: sometimes it directly drives damage, sometimes it contributes alongside other causes, and sometimes researchers are still establishing the connection.
For evidence about a bottle, begin with Longevity’s ingredient studies or Mobility’s ingredient studies. This page explains the broader health context.
DISEASE BIOLOGY / NOT PRODUCT TREATMENT CLAIMS
These explanations concern disease mechanisms and established care. The ingredient research answers a separate question: what an ingredient preparation achieved in supporting studies.
An autoimmune response sustains inflammation in the joint lining. It can damage cartilage and bone. Targeted treatments address disease activity as well as symptoms; less discomfort does not necessarily mean the disease is controlled.
NIAMS: rheumatoid arthritis See the supporting findingsPersistent inflammation in the digestive tract contributes to ulcers, symptoms and complications. Genes, immune responses, microbes and environmental factors also matter. Controlling disease activity is different from easing occasional digestive discomfort.
NIDDK: Crohn’s disease See the supporting findingsAbnormal immune responses cause inflammation and ulcers in the colon. Long-standing disease can increase colorectal-cancer risk. Symptom control, inflammation management and appropriate monitoring are distinct parts of care.
NIDDK: ulcerative colitis See the supporting findingsImmune activity drives inflammation and excessive skin-cell production. The visible patches reflect an underlying process influenced by genes and environment; they are more than a surface irritation.
NIAMS: psoriasis See the supporting findingsImmune-mediated inflammation affects joints and the places where tendons and ligaments attach to bone. Early treatment is associated with less damage. Ingredient research cannot establish that either formula controls this disease.
NIAMS: psoriatic arthritis See the supporting findingsInflammatory reactions contribute to airway swelling, sensitivity, mucus and narrowing. Triggers and disease types vary. Limited ingredient studies are a separate question from established asthma management.
NHLBI: asthma causes See the supporting findingsUrate crystals trigger the inflammatory response behind a painful flare. Reducing inflammation and reducing the underlying urate burden are different goals. Improvement in symptoms does not establish that crystals have disappeared.
NIAMS: goutAn abnormal immune response targets healthy tissue. Inflammation can injure joints, skin, kidneys and other organs. Its effects vary considerably, so the affected tissues and disease activity matter.
NIAMS: lupusSpecific inflammatory pathways contribute to atherosclerotic disease. Targeted trials provide evidence about those pathways, but cholesterol, smoking, blood pressure and other risks still matter. Drug-trial results are not evidence of supplement protection.
CANTOS: randomised cardiovascular trial See the supporting findingsInflammatory pathways interact with insulin-producing cells and metabolic function. A trial targeting interleukin-1 improved selected glucose and beta-cell measures. Diabetes has multiple mechanisms; this does not establish a universal anti-inflammatory treatment.
Interleukin-1 blockade trial See the supporting findingsIn MASH, fat accumulation, liver-cell injury and inflammation interact with scarring. The condition can progress to serious liver damage. Inflammation is part of that process, rather than its sole cause.
NIDDK: fatty-liver disease research See the supporting findingsPersistent inflammation can damage DNA and contribute to the development of certain cancers. This does not mean all cancers originate with inflammation. Curcumin’s laboratory effects do not establish cancer prevention or treatment in people.
NCI: chronic inflammation See the supporting findingsInflammation can accompany and contribute to symptoms within a condition affecting cartilage, bone and other joint tissues. Injury, joint loading, ageing and structural changes also matter. Pain and function are different from cartilage regeneration.
NIAMS: osteoarthritis See the supporting findingsImmune-mediated inflammation is an established component of disease activity and damage to myelin and nerve fibres. It does not explain every aspect of progression. Small ingredient studies do not establish disease modification.
NINDS: multiple sclerosis See the supporting findingsMicrobes and inflammation interact to damage the tissues and bone supporting teeth. Local mouthwash studies answer a different question from the effects of swallowed capsules.
NIDCR: gum disease See the supporting findingsIn IgA nephropathy, antibody deposits cause inflammation and damage in the kidney’s filtering structures. That mechanism does not explain all kidney disease. Kidney-function outcomes and itching relief are separate research questions.
NIDDK: IgA nephropathy See the supporting findingsNeuroinflammation and immune-cell dysfunction are active research subjects. Cause, consequence and relevance differ between conditions. Findings in selected populations do not establish dementia prevention or a general mood benefit.
NIA: the brain in Alzheimer’s disease See the supporting findingsPersistent low-grade inflammation and cellular senescence are important research areas. Their links with age-related changes do not establish that suppressing inflammation with a supplement extends human lifespan.
NIA: senescence and ageing researchFor exercise recovery, indigestion, allergies, menstrual symptoms, cluster headaches, treatment side effects and other ingredient questions, explore the supporting research across all nine health areas.
WHAT DOES ANTIOXIDANT SUPPORT MEAN?
Your cells encounter reactive molecules, including free radicals. Oxidative stress is the imbalance that occurs when these overwhelm the body’s antioxidant defences. Antioxidants help counter these reactions.
Researchers study curcumin’s effects on inflammatory signals and oxidative-stress measurements. An improvement in a laboratory marker does not, by itself, establish disease prevention or longer life.
LONGEVITY + MOBILITY
Longevity is the turmeric-led formula positioned around inflammation and antioxidant support. Mobility is the boswellia-led formula positioned around joint comfort and movement.
Laboratory research shows curcumin acting on inflammatory signalling, including NF-κB and COX-2.
Curcumin signalling researchLaboratory research links AKBA with 5-lipoxygenase inhibitory activity, a pathway involved in inflammatory signalling.
AKBA and 5-LOX researchA 12-week trial involving 201 people with knee osteoarthritis found that a curcumin–boswellia combination improved pain and physical-performance outcomes compared with placebo.
WHY INFLAMMATION MATTERS
Research connects persistent inflammation with health across the body. Human trials also show that changing an inflammatory pathway can change meaningful health outcomes.
In 10,061 people with previous heart attack and elevated inflammation, targeting a specific inflammatory pathway reduced recurrent major cardiovascular events by about 15%.
CANTOS trialIn people with H. pylori infection and a family history of gastric cancer, eradication treatment reduced gastric-cancer occurrence from 2.7% to 1.2% over a median 9.2 years.
H. pylori eradication trial